Ramucirumab: A Review in Advanced Gastric Cancer.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 341, doi. 10.1007/s40259-015-0138-1
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2015 AND VI 29 AND IP 5
Results: 6
1
2
Bivalent rLP2086 Vaccine (Trumenba): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 353, doi. 10.1007/s40259-015-0139-0
- By:
- Publication type:
- Article
3
Sipuleucel-T (Provenge)-Autopsy of an Innovative Paradigm Change in Cancer Treatment: Why a Single-Product Biotech Company Failed to Capitalize on its Breakthrough Invention.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 301, doi. 10.1007/s40259-015-0140-7
- By:
- Publication type:
- Article
4
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on Apremilast.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 327, doi. 10.1007/s40259-015-0144-3
- By:
- Publication type:
- Article
5
FDA Draft Guidance on the Naming of Biosimilars.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 323, doi. 10.1007/s40259-015-0146-1
- By:
- Publication type:
- Article
6
Pharmacovigilance Considerations for Biosimilars in the USA.
- Published in:
- BioDrugs, 2015, v. 29, n. 5, p. 309, doi. 10.1007/s40259-015-0137-2
- By:
- Publication type:
- Article